"If people were insects, there would be more approved drugs on the market."
A drug (to an ant) would be in the form of a new natural mutation showing up, such as a new variety of grass that spreads widely. As ants are omnivorous, the new variety would be consumed. Because there is no ant FDA, consumption is implicit approval.
But ants rarely travel more than 800 feet from their home, so across the country, each “approval” would be a local (and different) approval; so any given new grass variety (new drug) would be approved over and over again.
With each new mutation (whether effective as a therapeutic or not) being locally approved, and with wildly large numbers of communities giving their approval, the count of approved “drugs” can’t help but be dramatically greater than the current human score.
Allowing all insects into the evaluation rather than just the ants described above, would further increase the ant/human “drug approval” ratio.
rjc
